Antiviral aryl-amide phosphodiamide compounds
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Aug 11, 2020
Grant Date -
Aug 29, 2019
app pub date -
Oct 20, 2017
filing date -
Oct 26, 2016
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Compounds of Formula (I): (Formula (I)) and their pharmaceutically acceptable salts are useful for the inhibition of HIV reverse transcriptase. The compounds may also be useful for the prophylaxis or treatment of infection by HIV and in the prophylaxis, delay in the onset or progression, and treatment of AIDS. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antiviral agents, immunomodulators, antibiotics or vaccines.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully